Fecho Jeff 4
4 · ENDOLOGIX INC /DE/ · Filed Oct 1, 2019
Insider Transaction Report
Form 4
Fecho Jeff
Chief Quality Officer
Transactions
- Disposition to Issuer
Option to Purchase
2019-09-27−6,789→ 0 totalExercise: $56.70From: 2019-06-25Exp: 2028-06-25→ Common Stock (6,789 underlying) - Award
Option to Purchase
2019-09-27+2,263→ 2,263 totalExercise: $4.71From: 2020-09-10Exp: 2026-09-10→ Common Stock (2,263 underlying)
Footnotes (3)
- [F1]Thirty-three percent of the options vested upon one year of service and the remaining balance continued to vest in equal monthly installments thereafter.
- [F2]The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, an option for 6,789 shares of common stock granted to the reporting person on June 25, 2018. In exchange, the reporting person received a new stock option, for 2,263 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019.
- [F3]The options vest in three equal annual installments over a three-year period commencing on September 10, 2019.